Sophia Genetics SA
SOPH3.290USD
+0.130+4.11%
取引時間 （ET）15分遅れの株価
219.84M時価総額
損失額直近12ヶ月PER
詳細情報 Sophia Genetics SA 企業名
Sophia Genetics SA is a Switzerland-based company engaged in the software publishing sector. The Company offer a cloud-based Software-as-a-Service platform - the SOPHiA DDM, which is data-driven medicine platform enabling insights from disparate, complex datasets to improve diagnosis, treatment, and drug development. The Company has offices in Switzerland, France and the United Kingdom and operates worldwide.
企業情報
企業コードSOPH
会社名Sophia Genetics SA
上場日Jul 23, 2021
最高経営責任者「CEO」Dr. Jurgi Camblong, Ph.D.
従業員数423
証券種類Ordinary Share
決算期末Jul 23
本社所在地La Piece 12
都市ROLLE
証券取引所NASDAQ Global Select Consolidated
国Switzerland
郵便番号1180
電話番号41216941060
ウェブサイトhttps://www.sophiagenetics.com/
企業コードSOPH
上場日Jul 23, 2021
最高経営責任者「CEO」Dr. Jurgi Camblong, Ph.D.
役員一覧
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Jurgi Camblong, Ph.D.
Dr. Jurgi Camblong, Ph.D.
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
2.65M
+7.89%
Dr. Vincent Ossipow, Ph.D.
Dr. Vincent Ossipow, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
443.81K
+12.21%
Dr. Zhenyu Xu, Ph.D.
Dr. Zhenyu Xu, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
396.61K
-4.26%
Mr. Troy M. Cox
Mr. Troy M. Cox
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
234.25K
+25.98%
Mr. Didier Hirsch
Mr. Didier Hirsch
Non-Executive Independent Director
Non-Executive Independent Director
133.93K
+79.72%
Mr. Ross J Muken
Mr. Ross J Muken
President
President
128.13K
+108.22%
Ms. Manuela Da Silva Valente
Ms. Manuela Da Silva Valente
Chief People Officer
Chief People Officer
60.38K
+51.32%
Dr. Philippe Menu, M.D., Ph.D.
Dr. Philippe Menu, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
39.60K
-5.14%
Mr. Milton G. Silva-Craig, J.D.
Mr. Milton G. Silva-Craig, J.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. George A. Cardoza
Mr. George A. Cardoza
Chief Financial Officer
Chief Financial Officer
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Jurgi Camblong, Ph.D.
Dr. Jurgi Camblong, Ph.D.
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
2.65M
+7.89%
Dr. Vincent Ossipow, Ph.D.
Dr. Vincent Ossipow, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
443.81K
+12.21%
Dr. Zhenyu Xu, Ph.D.
Dr. Zhenyu Xu, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
396.61K
-4.26%
Mr. Troy M. Cox
Mr. Troy M. Cox
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
234.25K
+25.98%
Mr. Didier Hirsch
Mr. Didier Hirsch
Non-Executive Independent Director
Non-Executive Independent Director
133.93K
+79.72%
Mr. Ross J Muken
Mr. Ross J Muken
President
President
128.13K
+108.22%
収益内訳
通貨: USD更新時刻: Sun, Jul 6
通貨: USD更新時刻: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
データなし
地域別USD
会社名
収益
比率
Rest of EMEA
5.51M
31.00%
France
2.61M
14.70%
Italy
2.53M
14.23%
United States
2.48M
13.95%
Spain
1.42M
7.97%
Other
3.23M
18.15%
事業別
地域別
データなし
株主
更新時刻: Wed, Jul 23
更新時刻: Wed, Jul 23
株主統計
種類
株主統計
株主統計
比率
Alychlo NV
10.46%
Generation Investment Management LLP
10.16%
aMoon Fund
8.25%
UBS Asset Management (Switzerland)
6.79%
Akre Capital Management, LLC
5.57%
Other
58.78%
株主統計
株主統計
比率
Alychlo NV
10.46%
Generation Investment Management LLP
10.16%
aMoon Fund
8.25%
UBS Asset Management (Switzerland)
6.79%
Akre Capital Management, LLC
5.57%
Other
58.78%
種類
株主統計
比率
Investment Advisor
17.54%
Investment Advisor/Hedge Fund
16.07%
Venture Capital
13.28%
Family Office
10.52%
Individual Investor
6.53%
Hedge Fund
0.91%
Bank and Trust
0.46%
Pension Fund
0.14%
Other
34.55%
機関投資家保有株
更新時刻: Tue, Jul 1
更新時刻: Tue, Jul 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q2
89
36.68M
54.88%
-257.44K
2025Q1
93
36.63M
54.82%
-389.48K
2024Q4
93
32.50M
49.36%
-965.83K
2024Q3
91
34.60M
52.08%
+657.87K
2024Q2
92
32.44M
48.93%
+1.33M
2024Q1
93
31.91M
48.51%
+375.11K
2023Q4
91
30.61M
46.76%
-676.23K
2023Q3
91
30.34M
46.61%
-4.34M
2023Q2
90
31.34M
48.19%
-3.70M
2023Q1
86
30.07M
46.79%
+1.58M
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
Alychlo NV
6.99M
10.46%
--
--
Feb 15, 2025
Generation Investment Management LLP
6.79M
10.16%
--
--
Mar 31, 2025
aMoon Fund
5.51M
8.25%
+577.36K
+11.70%
Feb 15, 2025
UBS Asset Management (Switzerland)
4.54M
6.79%
+2.34M
+106.14%
Mar 31, 2025
Akre Capital Management, LLC
3.72M
5.57%
+1.48M
+66.22%
Jun 20, 2025
Balderton Capital (UK) LLP
3.36M
5.03%
--
--
Feb 15, 2025
UBS Asset Management (Americas) LLC
3.10M
4.64%
+3.10M
--
Mar 31, 2025
Camblong (Jurgi)
2.65M
3.97%
+194.16K
+7.89%
Feb 15, 2025
Banque Pictet & Cie S.A.
2.21M
3.31%
-32.20K
-1.44%
Mar 31, 2025
Principal Global Investors (Equity)
1.39M
2.07%
-43.33K
-3.03%
Mar 31, 2025
詳細を見る
関連ETF
更新時刻: Sat, Aug 2
更新時刻: Sat, Aug 2
銘柄名
比率
iShares Health Innovation Active ETF
0%
Fidelity Nasdaq Composite Index ETF
0%
iShares Health Innovation Active ETF
比率0%
Fidelity Nasdaq Composite Index ETF
比率0%
配当金
過去5年間の配当金総支払額は
0.00
米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし
株式分割
日付
種類
比率
データなし
日付
種類
比率
データなし
